Biolojic Design signs Merck deal potentially worth $373M
The ‘smart antibody’ maker will receive $10 mil. in the initial stage of the agreement to develop molecules that would be used in anti-cancer drugs.
Our shared future depends on innovating in the fields of science, business, healthcare and technology. Learn more about Israeli leaders in disruptive solutions, cutting-edge research, and other emerging trends that will positively impact our world.
The ‘smart antibody’ maker will receive $10 mil. in the initial stage of the agreement to develop molecules that would be used in anti-cancer drugs.
Founders say Heyoosh is the world’s first AI-based personal matchmaker that steers away from predatory tactics of Tinder and similar services.
Greeneye Technology’s precision spraying can offer farmers in and around Nebraska a major productivity boost.
Hervana’s hormone-free tablets, now under development, won’t disrupt a woman’s cycle and also offer protection from sexually transmitted diseases.
The Israeli company behind the world’s first saliva-based rapid pregnancy test is partnering with Sheba Medical Center to create oral cancer tests.
New startup Seven AI wins $36 million in funding for its software that reinvents the command center that monitors an organization’s IT infrastructure.
Kachol Balev matches war-affected companies in Israel with remote volunteers skilled in programming, software engineering, sales, marketing and more.
Senescence, a process long thought to be the “bad guy” behind aging, now shown to be essential in cardiac healing and regeneration.
Aporia’s Guardrails for Multimodal AI set to enhance the safety and reliability of the latest AI capabilities combining text, audio, video and images.
Sightful has opened preorders for its Spacetop G1 laptop, which boasts a 100-inch augmented reality screen visible only to the user
The dominant presence of Israeli cybersecurity is continued proof of the Israeli cyber market’s maturation.
By combining software with traditional pharmaceuticals, Remepy’s hybrid drugs promise personalized and more effective treatments for cancer, Parkinson’s and more.
The German company’s acquisition is one of the most expensive in 2024.
By using electrical currents, the in2 patch prolongs sexual intercourse in men suffering from premature ejaculation — if they can afford it.
The Strauss-owned company’s partnership with Mileutis is set to make milk better for consumers, improve welfare of cows and boost sustainability.